Equities
Health CareHealth Care Providers
  • Price (USD)219.23
  • Today's Change1.55 / 0.71%
  • Shares traded57.00
  • 1 Year change+9.75%
  • Beta1.5155
Data delayed at least 15 minutes, as of Nov 08 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.

  • Revenue in USD (TTM)15.32bn
  • Net income in USD1.41bn
  • Incorporated2016
  • Employees88.00k
  • Location
    IQVIA Holdings Inc2400 ELLIS ROADDURHAM 27703United StatesUSA
  • Phone+1 (919) 998-2000
  • Fax+1 (302) 636-5454
  • Websitehttps://ir.iqvia.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Iqvia Holdings Inc15.32bn1.41bn39.81bn88.00k28.765.7115.692.607.627.6283.0938.360.5762--4.77176,034.505.313.247.134.0735.1734.329.216.03--3.430.65980.003.987.5524.4743.397.17--
Data as of Nov 08 2024. Currency figures normalised to IQVIA Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

41.42%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202419.49m10.69%
Harris Associates LPas of 30 Jun 202410.67m5.85%
BlackRock Fund Advisorsas of 30 Jun 202410.32m5.66%
GIC Pte Ltd. (Investment Management)as of 13 Aug 20249.13m5.01%
SSgA Funds Management, Inc.as of 30 Jun 20248.03m4.40%
Geode Capital Management LLCas of 30 Jun 20244.22m2.32%
AllianceBernstein LPas of 30 Jun 20244.02m2.21%
Canada Pension Plan Investment Boardas of 30 Jun 20243.40m1.87%
Lazard Asset Management LLCas of 30 Jun 20243.29m1.80%
Farallon Capital Management LLCas of 30 Jun 20242.92m1.60%
More ▼
Data from 30 Jun 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.